(Reuters) – Pfizer Inc Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms.
Bourla said he had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.
Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)
